
Biotechnology • Pharmaceuticals • Healthcare Insurance
Enliven Therapeutics is a company dedicated to developing innovative solutions for cancer treatment. They focus on creating small molecule kinase inhibitors designed to improve efficacy, safety, and patient convenience. With programs targeting BCR-ABL, HER2, and additional pathways, Enliven Therapeutics aims to enhance the precision and selectivity of cancer therapeutics, combat resistance, and address brain metastases. The company prides itself on a team of experienced drug developers and aims to help cancer patients live longer and better lives.
November 4
Senior Director leading Drug Safety and Pharmacovigilance at Enliven Therapeutics. Responsible for safety and compliance in drug development for improving Oncology treatments.
September 26
Senior Director leading global regulatory strategy for oncology small-molecule programs at clinical-stage Enliven Therapeutics. Oversees regulatory submissions, health authority interactions, and cross-functional program leadership.
September 19
Director of Corporate Communications leading investor, media, and public messaging for Enliven Therapeutics. Translating complex oncology science into accessible narratives and managing IR.